What patients should pay attention to when using pemetinib

Pemetinib is an innovative drug used to treat biliary cholangiocarcinoma and certain types of malignant myeloid tumors/lymphoma. It belongs to the kinase inhibitor class of drugs, which inhibits the growth and spread of cancer cells by blocking the abnormally active kinase signaling pathways in cancer cells. Although pemetinib has brought new treatment hope to many patients, patients still need to pay special attention to the following points during use to ensure the safety and effectiveness of the treatment.

As a targeted therapy, pemetinib has significant efficacy, but it may also cause a series of side effects. Therefore, patients should pay close attention to their physical condition during medication. If symptoms of an allergic reaction, such as hives, difficulty breathing, or swelling of the face or throat, occur, stop taking the medication immediately and seek medical attention. These allergic symptoms can be life-threatening and must be taken seriously.

In addition, pemetinib may affect the eyes, causing problems such as blurred vision, dry eyes, increased tearing, or sensitivity to light. Patients should undergo regular eye examinations during use and report any discomfort to their doctor immediately. At the same time, pemetinib may also cause abnormalities in phosphate levels in the blood, manifesting as muscle spasms, numbness, or tingling around the mouth. This also requires patients to pay close attention and regularly check blood phosphate levels.

In addition to the specific side effects mentioned above, pemetinib may also cause some common side effects, such as nausea, vomiting, diarrhea, constipation, loss of appetite, mouth ulcers, dry mouth, joint pain, back pain, fatigue, dry skin, hair loss, and changes in taste. Although these side effects are usually mild, they may affect the patient's quality of life. Therefore, patients should maintain good living habits during medication, such as a balanced diet, moderate exercise, adequate rest, etc., to reduce the discomfort caused by side effects.

Finally, when using pemetinib, patients must inform their doctors of all their medical information, including other medications, supplements, and over-the-counter medications they are taking. This is because pemetinib may interact with other medications, affecting its efficacy or increasing the risk of adverse reactions. Through comprehensive evaluation and guidance from doctors, patients can be treated with pemetinib more safely and effectively.

xa0

Reference link:https://www.drugs.com/mtm/pemigatinib.html